Skip to main content
Log in

Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

Impaired fasting glucose (IFG) like impaired glucose tolerance (IGT) has increased risk of progressing to diabetes mellitus (DM). The aim of the study was to evaluate prevalance of IGT and type 2 DM with oral glucose tolerance test (OGTT) in Turkish patients who had fasting glucose of 110 and 125 mg/dl. Hundred and forty-eight (67.3%) women and 72 (32.7%) men (30–65 years old with mean age of 51.3 ± 8.7 year) who had fasting glucose range 110–125 mg/dl were evaluated with OGTT. Seventy-two patients had IGT (32.8%), 74 (33.6%) patients had type 2 diabetes and 74 (33.6%) patients had normal glucose tolerance (NGT). Mean fasting glucose and insulin levels were higher in the IGT group than in the NGT group. Mean level of total cholesterol was higher in DM than that in NGT and IGT groups. Mean triglyceride (TG) (P = 0.476), high-density lipoprotein (HDL) (P = 0.594), low-density lipoprotein (LDL) (P = 0.612), Apoproteine A (P = 0.876), Apoproteine B (P = 0.518), uric acid (P = 0.948) and ferritin (P = 0.314) were found higher in diabetic patients. Lipoproteine a (P = 0.083), fibrinogen (P = 0.175) and hsCRP (P = 0.621) levels were higher in IGT. Mean HOMA S% levels of NGT, IGT and DM were found to be 65.0 ± 13.0%, 60.9 ± 16.0% and 50.1 ± 11.1%, respectively. HOMA B% levels were measured to be 80.4 ± 29.1% in NGT, 85.3 ± 14.59% in IGT and 60.1 ± 10.1% in DM. Significant difference was found between IFG and DM (P = 0.043) groups. The prevalences of diabetes and IGT were found to be 33.63 and 32.7% in IFG, respectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Susman JL, Helseth LD (1997) Reducing the complications of type II diabetes: a patient-centered approach. Am Fam Physician 56:471–480

    PubMed  CAS  Google Scholar 

  2. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197

    Google Scholar 

  3. Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA (1997) Comparison of fasting 2-hour glucose and HbA levels for diagnosing diabetes: diagnostic criteria and performance revisited. Diabetes Care 20:785–791

    Article  PubMed  CAS  Google Scholar 

  4. Balkan B, Bertrais S, Ducimetiere P, Eschwege E (1999) Is there a glycaemic threshold for mortality risk? Diabetes Care 22:696–699

    Article  Google Scholar 

  5. National Diabetes Data Group (1979) Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039–1057

    Google Scholar 

  6. Harris MI (1996) Impaired glucose tolerance–prevalence and conversion to NIDDM. Diabet Med 13(Suppl 2):9–11

    Google Scholar 

  7. Harris MI, Hadden WC, Knowler WC, Benneth PH (1987) Prevelance of diabetes and impaired glucose tolerance and plazma glucose levels in US population aged 20–74. Diabetes 36:523–534

    Article  PubMed  CAS  Google Scholar 

  8. Hertzel C, Gerstein MD (2001) Fasting versus postload glucose levels: why the controversy? Diabetes Care 24:1855–1857

    Article  Google Scholar 

  9. Finch CF, Zimmet PZ, Alberti KGMM (1990) Determinig diabetes prevelance; a rational basis for the use of fasting plazma glucose consentation? Diabet Med 7:603–610

    Article  PubMed  CAS  Google Scholar 

  10. American Diabetes Assosiation (1997) Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183–1197

    Google Scholar 

  11. Charles MA, Balkan B (1996) Revision of diagnostic criteria for diabetes [letter]. Lancet 348:1657–1658

    Article  PubMed  CAS  Google Scholar 

  12. Alberti KGMM, Zimmet PZ, for the WHO Consultation Group (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part1: diagnosis classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539–553

  13. Harris MI, Flegal KM, Cowie C et al (1998) Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care 21:1518–1524

    Google Scholar 

  14. De Vegt F, Dekker JM, Stehouwer CDA, Nijpels G, Bouter LM, Heine RJ (1998) The 1997 American Diabetes Assosiation criteria versus the 1985 World Health Organization criteria for the diagnosis of abnormal glucose tolerance. Diabetes Care 21:1686–1690

    Article  PubMed  Google Scholar 

  15. Barrett-Connor E, Ferrara A (1998) Isolated postchallenge hyperglycemia and risk of fatal cardiovasculer diseases older women and men. Diabetes Care 21:1236–1239

    Article  PubMed  CAS  Google Scholar 

  16. Shaw JE, Hodge AM, de Courten M, Chitson P, Zimmet PZ (1999) İsolated postchallenge hyperglycemia confirmed as a risk factor of mortality. Diabetologia 42:1050–1054

    Article  PubMed  CAS  Google Scholar 

  17. Barzilay JI, Spiekerman CF, Wahl PW et al. (1999) Cardiovasculer diseases in older adults with glucose disorders: comparison of American Diabetes Association criteria for diabetes mellitus with WHO criteria. Lancet 354:1622–1655

    Google Scholar 

  18. DECODE Study Group, for the European Diabetes Epidemiology Group (1999) Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic crireria. Diabetes epidemiology: collaborative analysis of diagnostic criteria in Europe. Lancet 354:617–621

    Google Scholar 

  19. Alberti KGMM (1996) The clinical implications of impaired glucose tolerance. Diabet Med 13:1927–1937

    Article  Google Scholar 

  20. Unwin N, Shaw J, Zimmet P, Alberti KG (2002) Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention. Diabet Med 19:1708–1723

    Google Scholar 

  21. UK Prospective Diabetes Study Group (1998) Tight blood preasure control and risk of macrovascular and microvascular complications in type 2 diabetes (UKPDS 38). BMJ 317:1703–1713

    Google Scholar 

  22. American Diabetes Association (2005) Diagnosis and classification of diabetes mellitus. Diabetes Care 28:37–42

    Article  Google Scholar 

  23. Oxford Diabetes web site Oxford Centre for Diabetes, Endocrinology and Metabolism—website. The Diabetes Trials Unit. http://www.dtu.ox.ac.uk/

  24. Matsuda M, DeFronzo RA (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22(9):1462–1470

    Article  PubMed  CAS  Google Scholar 

  25. Stumvoll M, Van Haeften T, Fritsche A, Gerich J (2001) Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times. Diabetes Care 24(4):796–797

    Article  PubMed  CAS  Google Scholar 

  26. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA, Dwyer T, Colagiuri S, Jolley D, Knuiman M, Atkins R, Shaw JE (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care 25:1829–1834

    Article  Google Scholar 

  27. Jensen CC, Cnop M, Hull RL, Fujimato WY, Kahn SE, for the American Diabetes Assosiation GENNİD Study Group (2002) Beta-cell function is a major contributor to oral glucose tolerance in high-risk relatives of four ethnic groups in the U.S. Diabetes 5:2170–2178

    Google Scholar 

  28. Perry IJ, Wannamethee SG, Walker MK, Thomson AG, Whincup PH, Shaper AG (1995) Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ 310:560–564

    PubMed  CAS  Google Scholar 

  29. Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X, Mo J, Whelton PK, HeJ (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: international collaborative study of cardiovascular disease in Asia (InterASIA). Diabetologia 46:1190–1198

    Article  PubMed  CAS  Google Scholar 

  30. Weyer C, Bogardus C, Pratley RE (1999) Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. Diabetes 48:2197–2203

    Article  PubMed  CAS  Google Scholar 

  31. Abdul-Ghani MA, Tripathy D, DeFronzo RA (2006) Contributions of {beta}-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care 29:1130–1139

    Article  PubMed  CAS  Google Scholar 

  32. Davies MJ, Raymond NT, Day JL, Hales C, Burden AC (2000) Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med 17:433–440

    Article  PubMed  CAS  Google Scholar 

  33. Shaw JE, Zimmet PZ, de Courten M, Dowse GK, Chitson P, Gareeboo H, Hemraj F, Fareed D, Tuomilehto J, Alberti KG (1999) Impaired fasting glucose or impaired glucose tolerance: what best predicts future diabetes in Mauritius? Diabetes Care 22:399–402

    Article  PubMed  CAS  Google Scholar 

  34. Gabir MM, Hanson RL, Dabelea D, Imperatore G, Roumain J, Bennett PH, Knowler WC (2000) The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 23:1108–1112

    Article  PubMed  CAS  Google Scholar 

  35. The DECODE Study Group, for the European Diabetes Epidemiology Study Group (1998) Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 317:371–375

    Google Scholar 

  36. Davidson MB, Peters AL, Schriger DL (1995) An alternative approach to the diagnosis of diabetes with a review of the literature. Diabetes Care 8:1065–1071

    Google Scholar 

  37. Abdul-Ghani M, Williamsn K, DeFronzo R, Stern M (2006) Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care 29:1613–1618

    Article  PubMed  CAS  Google Scholar 

  38. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R (2003) The natural history of progression from normal glucose tolerace to type 2 diabetes in the Baltimore longitudinal study of aging. Diabetes 52:1475–1484

    Article  PubMed  CAS  Google Scholar 

  39. Williams JW, Zimmet PZ, Shaw JE, de Courten MP, Cameron AJ, Chitson P, Tuomilehto J, Alberti KG (2003) Gender differences in the prevalence of impaired fasting glycaemia and impaired glucose tolerance in Mauritius. Does sex matter? Diabet Med 20:915–20

    Article  PubMed  CAS  Google Scholar 

  40. The DECODE Study Group (2002) Age, body mass index and glucose tolerance in 11 European population-based surveys. Diabet Med 19:558–565

    Article  Google Scholar 

  41. Dunstan DW, Zimmet PZ, Welborn TA, De Courten MP, Cameron AJ, Sicree RA (2002) The rising prevalence of diabetes and impaired glucose tolerance: the Australian diabetes, obesity and lifestyle study. Diabetes Care 25:829–834

    Article  PubMed  Google Scholar 

  42. Zargar AH, Khan AK, Masoodi SR, Laway BA, Wani AI, Bashir MI et al (2000) Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in the Kashmir Valley of the Indian subcontinent. Diabetes Res Clin Pract 47:135–146

    Article  PubMed  CAS  Google Scholar 

  43. Omar MA, Seedat MA, Dyer RB, Motala AA, Knight LT, Becker PJ (1994) South African Indians show a high prevalence of NIDDM and bimodality in plasma glucose distribution patterns. Diabetes Care 17:70–73

    Article  PubMed  CAS  Google Scholar 

  44. Tripathy D, Carlsson M, Almgren P, Isomaa B, Taskinen MR, Tuomi T, Groop LC (2000) Insulin secretion and insulin sensitivity in relation to glucose tolerance: lessons from the Botnia study. Diabetes 49:975–980

    Article  PubMed  CAS  Google Scholar 

  45. Davies MJ, Raymond NT, Day JL, Hales CN, Burden AC (2000) Impaired glucose tolerance and fasting hyperglycaemia have different characteristics. Diabet Med 17:433–440

    Article  PubMed  CAS  Google Scholar 

  46. Güney E, Özgen G, Kısakol G (2002) Impact of new diagnostic criteria on the frequency of diabetes mellitus and prediabetic conditions. Int J Diabetes Metab 10:22–28

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fulden Saraç.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tutuncuoğlu, P., Saraç, F., Saygılı, F. et al. Diabetes and impaired glucose tolerance prevalences in Turkish patients with impaired fasting glucose. Acta Diabetol 45, 151–156 (2008). https://doi.org/10.1007/s00592-008-0034-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-008-0034-y

Keywords

Navigation